Chase AIBulk Dataset ExportPricingFAQsBlog
Display currency
Loading news…

Dark Blue Therapeutics

ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals.
Oxford, Oxfordshire, United Kingdom Founded 2020 11-50 employees For Profit

Dark Blue Therapeutics develops oncology medicines targeting cancer through drug discovery.

Dark Blue Therapeutics on Acquirezy — acquisitions, funding rounds, investments, investors, key people & contacts.

Dark Blue Therapeutics was acquired by Amgen in 2026 for $840M.
Last Funding
Acquisitions
0
Monthly Visits
Contacts
2
Patents
4

About Dark Blue Therapeutics

Funding & Financials

Total funding
Funding rounds
Last funding
Last funding type
Last funding date
Funding status
Total equity funding
Revenue range

IPO & Stock

IPO status
Private

Web Traffic

Monthly visits
Global traffic rank
6-mo avg visits
Visit duration (s)
Pages / visit
Bounce rate
Rank change (mo)

Technology & IP

Active technologies
3
Patents granted
4
Trademarks
0
Top patent class
Organic Chemistry
IT spend
$7.33K

Company Info

Founded
2020
Employees
11-50
Operating status
Active
Company type
For Profit
Org types
company
News articles
40
HQ
Oxford, Oxfordshire, United Kingdom
Region
Europe, Middle East, and Africa (EMEA)
Exit date
Jan 6, 2026

Signals & Scores

Heat score
Low
Growth score
Low
Trend (7d)
0
Trend (30d)
-0.3
Trend (90d)
0.1
2
professional contacts at Dark Blue Therapeutics
Contact execs at Dark Blue Therapeutics

Explore 200,000+ acquisitions — free

Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.

Explore all acquisitions
Bulk Dataset Export

Need the data in bulk? Buy the entire dataset.

5.4M company profiles200K+ acquisitions700K+ funding rounds327K investors2M+ people61M contacts45K schools

Delivered as CSV, JSON or Parquet — at startup-friendly pricing.

See bulk export

Recent News related to Dark Blue Therapeutics

Loading news…

FAQs about Dark Blue Therapeutics

People who checked this page also checked these

Browse the full Acquirezy directory.
Dark Blue Therapeutics — Company Profile